Eisai R&d Management Co., Ltd.

National Cancer Center

Saori Miyano

Yasuhiro Funahashi

Akihiko Tsuruoka

Yuji Yamamoto

Kenichi Nomoto

Takayuki Nakagawa

Atsumi Yamaguchi

Tatsuhiro Shibata

Hajime Shimizu

Yasuhito Arai

Tomio Nakamura

Satoshi Goda

Yukinori Minoshima

Michio Kanekiyo

Taisuke Hoshi

The present application discloses a therapeutic agent for breast cancer, comprising 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or a pharmacologically acceptable salt thereof.

Therapeutic agent for breast cancer

The present invention provides a therapeutic agent for bile duct cancer comprising 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or a pharmacologically acceptable salt thereof.

Therapeutic agent for bile duct cancer

Disclosed is a therapeutic agent for hepatocellular carcinoma, comprising 5-((2-(4-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or a pharmacologically acceptable salt thereof.

Therapeutic agent for hepatocellular carcinoma

Growing community of inventors

Tsukubamirai, Japan

Saori Miyano